BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35402076)

  • 21. MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation.
    Alexander MS; Kawahara G; Motohashi N; Casar JC; Eisenberg I; Myers JA; Gasperini MJ; Estrella EA; Kho AT; Mitsuhashi S; Shapiro F; Kang PB; Kunkel LM
    Cell Death Differ; 2013 Sep; 20(9):1194-208. PubMed ID: 23764775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.
    Nguyen Q; Lim KRQ; Yokota T
    Appl Clin Genet; 2019; 12():113-130. PubMed ID: 31308722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
    Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
    J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of miR-200c in Myogenic Differentiation Impairment via p66Shc: Implication in Skeletal Muscle Regeneration of Dystrophic
    D'Agostino M; Torcinaro A; Madaro L; Marchetti L; Sileno S; Beji S; Salis C; Proietti D; Imeneo G; C Capogrossi M; De Santa F; Magenta A
    Oxid Med Cell Longev; 2018; 2018():4814696. PubMed ID: 29636844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy.
    Krishnan SM; Nordlohne J; Dietz L; Vakalopoulos A; Haning P; Hartmann E; Seifert R; Hüser J; Mathar I; Sandner P
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle.
    Chen D; Goswami CP; Burnett RM; Anjanappa M; Bhat-Nakshatri P; Muller W; Nakshatri H
    Cancer Res; 2014 Aug; 74(16):4270-81. PubMed ID: 24980554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy.
    Klimczak A; Zimna A; Malcher A; Kozlowska U; Futoma K; Czarnota J; Kemnitz P; Bryl A; Kurpisz M
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
    Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gene therapy for muscular dystrophy].
    Takeda S
    No To Hattatsu; 2004 Mar; 36(2):117-23. PubMed ID: 15031985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
    Parvatiyar MS; Marshall JL; Nguyen RT; Jordan MC; Richardson VA; Roos KP; Crosbie-Watson RH
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26702077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
    Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
    Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice.
    Anderson CL; De Repentigny Y; Cifelli C; Marshall P; Renaud JM; Worton RG; Kothary R
    Mol Ther; 2006 Nov; 14(5):724-34. PubMed ID: 16807118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced dimethylarginine degradation improves coronary flow reserve and exercise tolerance in Duchenne muscular dystrophy carrier mice.
    Garbincius JF; Merz LE; Cuttitta AJ; Bayne KV; Schrade S; Armstead EA; Converso-Baran KL; Whitesall SE; D'Alecy LG; Michele DE
    Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H582-H603. PubMed ID: 32762558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle Weakness in Myositis: MicroRNA-Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies.
    Kinder TB; Heier CR; Tully CB; Van der Muelen JH; Hoffman EP; Nagaraju K; Fiorillo AA
    Arthritis Rheumatol; 2020 Jul; 72(7):1170-1183. PubMed ID: 32009304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic overexpression of miR-133a in skeletal muscle.
    Deng Z; Chen JF; Wang DZ
    BMC Musculoskelet Disord; 2011 May; 12():115. PubMed ID: 21615921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
    Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
    Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.
    Nguyen HH; Jayasinha V; Xia B; Hoyte K; Martin PT
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5616-21. PubMed ID: 11960016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy.
    Rooney JE; Gurpur PB; Burkin DJ
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7991-6. PubMed ID: 19416897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.